aTyr Investigative Site

Washington D.C., District of Columbia 20060

0 studies enrolling now · 2 studies all time

What they study most

Pulmonary Sarcoidosis, SARS-CoV-2 (COVID-19) Severe Pneumonia

Studies at this site

• Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis — Completed
• Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19 — Completed